Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission 
Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug 
Pfizer Secures $10 Billion Deal for Obesity Drug Developer Metsera, Outbids Novo Nordisk 
Ireland Limits Planned Trade Ban on Israeli Settlements to Goods Only 
US Charges Two Men in Alleged Nvidia Chip Smuggling Scheme to China 
Southwest Airlines Has $11 Million Fine Waived as USDOT Cites Operational Improvements 
Thailand Vows Continued Military Action Amid Cambodia Border Clash Despite Trump Ceasefire Claim 
China Adds Domestic AI Chips to Government Procurement List as U.S. Considers Easing Nvidia Export Curbs 
Federal Judge Orders Restoration of SEVIS Status for Tufts PhD Student Rumeysa Ozturk 
CDC Vaccine Review Sparks Controversy Over Thimerosal Study Citation 
Trump Signs Executive Order to Establish National AI Regulation Standard 
Trump Backs Review of U.S. Childhood Vaccine Schedule After Hepatitis B Policy Change 
U.S. Special Forces Intercept Ship Carrying Military Components Bound for Iran 
Trump Set to Begin Final Interviews for Next Federal Reserve Chair 
SpaceX Starship Explodes in Texas During Test, Citing Nitrogen Tank Failure 
Ukraine, US and Europe Seek Unified Peace Framework With Security Guarantees for Kyiv 
FDA Pilot Program Eases Rules for Nicotine Pouch Makers 
U.S. President Donald Trump has signed an executive order aimed at expanding the use of artificial intelligence (AI) in pediatric cancer research. The order provides an additional $50 million in research grants to accelerate progress in finding cures for childhood cancers, according to White House officials.
This move builds on the National Cancer Institute’s (NCI) Childhood Cancer Data Initiative, a decade-long, $500 million program launched in 2019 to collect and share vital data on pediatric cancers. Michael Kratsios, director of the White House Office of Science and Technology Policy, highlighted that childhood cancer remains the leading cause of disease-related deaths among children in the United States, with cases rising more than 40% since 1975.
Kratsios noted that advances in AI can now be harnessed to sharpen diagnoses, improve clinical trials, fine-tune treatment strategies, and enhance prevention methods. Data gathered through the NCI initiative is expected to empower researchers with new tools to tackle the complexity and diversity of pediatric cancers.
In addition to the $50 million in grants, the National Institutes of Health (NIH) will double its commitment by investing another $50 million. This funding aims to attract leading scientific teams through competitive research opportunities. Further investments are also anticipated to strengthen ongoing initiatives.
The announcement comes despite Trump’s 2026 budget proposal, which suggested a 37% cut to the NCI budget. Lawmakers in both the House and Senate, however, have pushed back against these cuts, and budget negotiations remain ongoing.
Globally, the World Health Organization reports that around 400,000 children and adolescents are diagnosed with cancer each year. While advances in adult cancer research have surged with AI, pediatric cancer research has lagged due to challenges like cancer rarity, diversity, and ethical concerns over patient data protection.
By reinforcing funding and leveraging AI, the administration aims to close this gap and accelerate life-saving innovations in childhood cancer treatment.
